Long-term solid fuel use and risks of major eye diseases in China: A population-based cohort study of 486,532 adults plos.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from plos.org Daily Mail and Mail on Sunday newspapers.
Sri Lanka sees good results with donated vaccines from China By ARUNAVA DAS in Kolkata, India and XU WEIWEI in Hong Kong | China Daily Global | Updated: 2021-07-22 09:23 Share CLOSE A woman receives the Sinopharm vaccine in Colombo, Sri Lanka, on July 15. ISHARA S. KODIKARA/AFP
The COVID-19 vaccine developed by China s Sinopharm Group is highly effective in combating the novel coronavirus, according to a study by a leading university in Sri Lanka, which is speeding up vaccination against the pandemic.
Researchers at Sri Jayewardenepura University found that 95 percent of recipients of the Sinopharm vaccine developed antibodies against SARS-CoV-2, the virus that causes COVID-19.
Sickle Cell Disease, Trait May Up Risk for Poor COVID Outcomes medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Tuesday, 20 July 2021 - 8:20
The Allergy, Immunology & Cell Biology Unit of the Sri Jayawardanapura University has investigated immune responses to the Sinopharm vaccine and have found that the vaccine induced antibody responses in over 95% of individuals in Sri Lanka, similar to levels seen following natural COVID-19 illness.
The Sinopharm vaccine was found very effective for the Delta variant as well. The antibody responses to delta variant and neutralizing antibodies, were similar to levels seen following natural infection according to Prof Neelika Malawige and Dr. Chandima Jeewandara.
Click here for the report Full Report
The report on the Sri Jayawardanapura University website says the following;
Date Time
Study challenges recommended wait time between pregnancies
New Curtin University-led research has called into question existing health advice that mothers wait a minimum of two years after giving birth to become pregnant again, in order to reduce the risk of adverse pregnancy outcomes, such as preterm and small-for-gestational age births.
The research found that a World Health Organization (WHO) recommendation to wait at least 24 months to conceive after a previous birth may be unnecessarily long for mothers in high-income countries such as Australia, Finland, Norway and the United States.
Lead researcher Dr Gizachew Tessema from the Curtin School of Population Health said because the WHO advice was based on limited evidence from resource-limited countries, it was necessary to investigate whether the 15-year-old recommendation was relevant for higher-income settings.